Artificial Intelligence (AI) is transforming industries, and drug development is no exception. The regulatory lifecycle, a critical part of therapeutic drug development, offers numerous opportunities for AI to streamline processes, reduce errors, and accelerate time to market.How do you effectively incorporate AI into this complex lifecycle? It requires a thoughtful approach and a clear framework to ensure success, which we present here as five key elements.
Commentary
The regulatory lifecycle + AI
Related resources
Release note
Weave Platform February 2026 release notes
The February 2026 Weave Platform release introduces new capabilities that help teams review documents faster and simplify publishing workflows across…
Read more
Commentary
Scientific Rigor at Speed: Trace Biosciences’ First IND Experience
Trace Biosciences recently prepared and submitted its first Investigational New Drug (IND) application while advancing a nerve-targeted molecular imaging agent…
Read more
Commentary
Good AI Practice and the Regulatory Lifecycle
As artificial intelligence becomes more embedded in drug development, regulatory expectations for AI are rapidly evolving. In January 2026, the…
Read more
Product brochure
HAQ Manager
HAQ Manager provides a structured workspace for drafting, organizing, and reviewing health authority questions—keeping questions, responses, and supporting materials connected…
Read more